These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 23898097

  • 1. Etoposide improves survival in high-grade glioma: a meta-analysis.
    Leonard A, Wolff JE.
    Anticancer Res; 2013 Aug; 33(8):3307-15. PubMed ID: 23898097
    [Abstract] [Full Text] [Related]

  • 2. Vincristine in high-grade glioma.
    Aydin B, Patil M, Bekele N, Wolff JE.
    Anticancer Res; 2010 Jun; 30(6):2303-10. PubMed ID: 20651384
    [Abstract] [Full Text] [Related]

  • 3. [Chemotherapy of malignant inoperable gliomas. The association of fotemustine-cisplatine-etoposide as neoadjuvants].
    Frenay M, Lebrun C, Lonjon M, Marcy PY, Paquis P.
    Rev Neurol (Paris); 2000 Jan; 156(1):53-8. PubMed ID: 10693259
    [Abstract] [Full Text] [Related]

  • 4. [Radiotherapy of malignant brain gliomas using teniposide].
    Mufazalov FF, Sakaeva DD, Shtefan AIu.
    Vopr Onkol; 2008 Jan; 54(2):208-10. PubMed ID: 18522171
    [Abstract] [Full Text] [Related]

  • 5. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M, Müller B, Koch R, Bamberg M, Krauseneck P, Neuro-Oncology Working Group of the German Cancer Society.
    J Clin Oncol; 2003 Sep 01; 21(17):3276-84. PubMed ID: 12947063
    [Abstract] [Full Text] [Related]

  • 6. Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation.
    Giannone L, Wolff SN.
    Cancer Treat Rep; 1987 Sep 01; 71(7-8):759-61. PubMed ID: 3038317
    [Abstract] [Full Text] [Related]

  • 7. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
    Mizumatsu S, Matsumoto K, Maeda Y, Tamiya T, Furuta T, Ohmoto T.
    Gan To Kagaku Ryoho; 1998 Nov 01; 25(13):2055-60. PubMed ID: 9838907
    [Abstract] [Full Text] [Related]

  • 8. Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol.
    Wolff JE, Driever PH, Erdlenbruch B, Kortmann RD, Rutkowski S, Pietsch T, Parker C, Metz MW, Gnekow A, Kramm CM.
    Cancer; 2010 Feb 01; 116(3):705-12. PubMed ID: 19957326
    [Abstract] [Full Text] [Related]

  • 9. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C, Andratschke N, Wiedenmann N, Busch R, Grosu AL, Molls M.
    Strahlenther Onkol; 2004 Jul 01; 180(7):401-7. PubMed ID: 15241527
    [Abstract] [Full Text] [Related]

  • 10. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y.
    Pediatr Blood Cancer; 2004 Jul 01; 43(1):46-54. PubMed ID: 15170889
    [Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K, Kanaya H, Fujiyama Y, Kim P.
    Acta Neurochir (Wien); 2002 Dec 01; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [Abstract] [Full Text] [Related]

  • 12. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H.
    Ann Surg Oncol; 2008 Oct 01; 15(10):2887-93. PubMed ID: 18636295
    [Abstract] [Full Text] [Related]

  • 13. Response to a phase II study of concomitant-to-sequential use of etoposide and radiation therapy in newly diagnosed malignant gliomas.
    Beauchesne P, Soler C, Boniol M, Schmitt T.
    Am J Clin Oncol; 2003 Jun 01; 26(3):e22-7. PubMed ID: 12796612
    [Abstract] [Full Text] [Related]

  • 14. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW.
    Clin Cancer Res; 2003 Mar 01; 9(3):981-90. PubMed ID: 12631596
    [Abstract] [Full Text] [Related]

  • 15. A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas.
    Raizer JJ, Grimm S, Chamberlain MC, Nicholas MK, Chandler JP, Muro K, Dubner S, Rademaker AW, Renfrow J, Bredel M.
    Cancer; 2010 Nov 15; 116(22):5297-305. PubMed ID: 20665891
    [Abstract] [Full Text] [Related]

  • 16. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE, Tsujii H, Hasegawa A, Yanagi T, Takagi R, Kamada T, Tsuji H, Takakura K, Organizing Committee of the Central Nervous System Tumor Working Group.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):390-6. PubMed ID: 17459607
    [Abstract] [Full Text] [Related]

  • 17. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M, Molenaar W, Go GK.
    Strahlenther Onkol; 2003 Sep 01; 179(9):606-14. PubMed ID: 14628126
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials.
    Hofer S, Elandt K, Greil R, Hottinger AF, Huber U, Lemke D, Marosi C, Ochsenbein A, Pichler J, Roelcke U, Weder P, Zander T, Wick W, Weller M.
    Acta Oncol; 2011 Jun 01; 50(5):630-5. PubMed ID: 21495907
    [Abstract] [Full Text] [Related]

  • 19. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
    Wu SX, Deng ML, Li QQ, Zhao C, Lu TX, Li FY, Cui NJ.
    Ai Zheng; 2004 Nov 01; 23(11 Suppl):1561-6. PubMed ID: 15566680
    [Abstract] [Full Text] [Related]

  • 20. Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas.
    Chamberlain MC.
    Cancer; 2010 Sep 01; 116(17):3988-99. PubMed ID: 20564141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.